Who invested in Receptos?
Receptos's investors include Venrock, ARCH Venture Partners, Flagship Pioneering, LLC, Lilly Ventures and OrbiMed, and 1 more on record.
United States · Venture startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $11M sold, first sale Feb 2012
No investor was named in the report.
Reported by sec.govSEC filing: $11M sold, first sale Feb 2012
Reported by fiercebiotech.com
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Receptos's investors include Venrock, ARCH Venture Partners, Flagship Pioneering, LLC, Lilly Ventures and OrbiMed, and 1 more on record.
Receptos has raised $73M across 4 rounds since 2009.
Receptos's most recent round was a Venture of $30M in Mar 2012.
Its most recent round, $30M in Mar 2012, is also its largest on record.
Receptos's first round on record, in Nov 2009, was backed by Venrock, ARCH Venture Partners and Flagship Pioneering, LLC and 1 others.
Receptos's latest named round is a Venture, in Mar 2012.
Receptos is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.